Abstract
Introduction
Salivary gland cancer (SGC) is a rare malignant tumor arising from the salivary glands, with a variety of clinical and biological behaviors different from head and neck cancer (HNC). Because of the rarity of SGC, there are limited data on pre-treatment quality of life (QoL). Therefore, we evaluated the pre-treatment QoL in SGC patients by stage and compared it with that of HNC patients.
Methods
From a prospective registry of HNC patients (2016–2020), we selected 225 patients with SGC, and 912 patients with oral cavity (OC) and oropharyngeal cancer (OPC) who were diagnosed in the same period as the HNC control group. The European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire Core 30 (QLQ-C30) and HNC-Specific Module (H&N35) were used to assess QoL.
Results
SGC patients had a statistically better baseline QoL (69.8 vs. 64.0), emotional (82.1 vs. 78.8), cognitive (92.0 vs. 88.7), and social function (86.3 vs. 80.5), and fewer symptoms than HNC patients. The estimated average QoL differences between SGC patient diagnosed at stages I and IV was −12.9. Especially, advanced-stage of tumors was associated with much lower role functioning and emotional functioning scores in SGC patients, compared to those in HNC patients, among females and of younger age.
Discussion
Although the overall QoL score was higher in SGC patients than in HNC patients, specific domains were significantly affected in SGC patients according to the tumor stage. Females and those of younger age were more affected by severity of disease in SGC.
Study registration: ClinicalTrials.gov Identifier NCT02546895.
Similar content being viewed by others
Data availability
The data that support the findings of this study are available on request from the corresponding author (HSJ). The data are not publicly available due to their containing information that could compromise the privacy of research participants.
References
Del Signore, A. G., & Megwalu, U. C. (2017). The rising incidence of major salivary gland cancer in the United States. Ear, Nose, and Throat Journal, 96(3), E13–E16.
Pinkston, J. A., & Cole, P. (1999). Incidence rates of salivary gland tumors: Results from a population-based study. Otolaryngology—Head and Neck Surgery, 120(6), 834–840.
Fu, J. Y., Wu, C. X., Shen, S. K., Zheng, Y., Zhang, C. P., & Zhang, Z. Y. (2019). Salivary gland carcinoma in Shanghai (2003–2012): An epidemiological study of incidence, site and pathology. BMC Cancer, 19(1), 350.
Bradley, P. J., & McGurk, M. (2013). Incidence of salivary gland neoplasms in a defined UK population. British Journal of Oral and Maxillofacial Surgery, 51(5), 399–403.
Geiger, J. L., Ismaila, N., Beadle, B., Caudell, J. J., Chau, N., Deschler, D., et al. (2021). Management of Salivary Gland Malignancy: ASCO Guideline. Journal of Clinical Oncology, 39(17), 1909–1941.
Haslam, A., Herrera-Perez, D., Gill, J., & Prasad, V. (2020). Patient experience captured by quality-of-life measurement in oncology clinical trials. JAMA Network Open, 3(3), e200363.
Joly, F., Vardy, J., Pintilie, M., & Tannock, I. F. (2007). Quality of life and/or symptom control in randomized clinical trials for patients with advanced cancer. Annals of Oncology, 18(12), 1935–1942.
Roila, F., & Cortesi, E. (2001). Quality of life as a primary end point in oncology. Annals of Oncology, 12(Suppl 3), S3-6.
Stenner, M., Beenen, F., Hahn, M., Koopmann, M., Weiss, D., & Huttenbrink, K. B. (2016). Exploratory study of long-term health-related quality of life in patients with surgically treated primary parotid gland cancer. Head and Neck, 38(1), 111–117.
Becker, C., Pfeiffer, J., Lange, K., & Dahlem, K. K. K. (2018). Health-related quality of life in patients with major salivary gland carcinoma. European Archives of Oto-Rhino-Laryngology, 275(4), 997–1003.
Al-Mamgani, A., van Rooij, P., Verduijn, G. M., Meeuwis, C. A., & Levendag, P. C. (2012). Long-term outcomes and quality of life of 186 patients with primary parotid carcinoma treated with surgery and radiotherapy at the Daniel den Hoed Cancer Center. International Journal of Radiation Oncology Biology Physics, 84(1), 189–195.
Steffens, D., Solomon, M., Vuong, K., Alchin, L., Roberts, R., Koh, C., et al. (2018). Effect of timing on baseline quality of life scores among surgical cancer patients. BMC Research Notes, 11(1), 210.
van Leeuwen, M., Husson, O., Alberti, P., Arraras, J. I., Chinot, O. L., Costantini, A., et al. (2018). Understanding the quality of life (QOL) issues in survivors of cancer: Towards the development of an EORTC QOL cancer survivorship questionnaire. Health and Quality of Life Outcomes, 16(1), 114.
Karvonen-Gutierrez, C. A., Ronis, D. L., Fowler, K. E., Terrell, J. E., Gruber, S. B., & Duffy, S. A. (2008). Quality of life scores predict survival among patients with head and neck cancer. Journal of Clinical Oncology, 26(16), 2754–2760.
Jin, H., Kim, B. Y., Kim, H., Lee, E., Park, W., Choi, S., et al. (2019). Incidence of postoperative facial weakness in parotid tumor surgery: A tumor subsite analysis of 794 parotidectomies. BMC Surgery, 19(1), 199.
Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., et al. (1993). The European organization for research and treatment of cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85(5), 365–376.
Bjordal, K., de Graeff, A., Fayers, P. M., Hammerlid, E., van Pottelsberghe, C., Curran, D., et al. (2000). A 12 country field study of the EORTC QLQ-C30 (version 30) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients EORTC Quality of Life Group. European Journal of Cancer, 36(14), 1796–1807.
Yun, Y. H., Bae, S. H., Kang, I. O., Shin, K. H., Lee, R., Kwon, S. I., et al. (2004). Cross-cultural application of the Korean version of the European organization for research and treatment of cancer (EORTC) breast-cancer-specific quality of life questionnaire (EORTC QLQ-BR23). Supportive Care in Cancer, 12(6), 441–445.
Fayers, P. M., Aaronson, N. K., & Bjordal, K. (2001). The EORTC QLQ-C30 Scoring Manual (3rd ed.). European Organization for Research and Treatment of Cancer.
Cocks, K., King, M. T., Velikova, G., Fayers, P. M., & Brown, J. M. (2008). Quality, interpretation and presentation of European organisation for research and treatment of cancer quality of life questionnaire core 30 data in randomised controlled trials. European Journal of Cancer, 44(13), 1793–1798.
Park, S. I., Park, W., Choi, S., Jang, Y., Kim, H., Kim, S. H., et al. (2020). Clinical outcome of minor salivary gland cancers in the oral cavity: A comparative analysis with squamous cell carcinomas of the oral cavity. Frontiers in Oncology, 10, 881.
Hammerlid, E., Adnan, A., & Silander, E. (2017). Population-based reference values for the European organization for research and treatment of cancer head and neck module. Head and Neck, 39(10), 2036–2047.
Hamilton, S. N., Tran, E., Ho, C., Berthelet, E., Wu, J., DeVries, K., et al. (2021). Patient-reported outcome measures in patients undergoing radiotherapy for head and neck cancer. Supportive Care in Cancer, 29(5), 2537–2547.
Hammerlid, E., Bjordal, K., Ahlner-Elmqvist, M., Boysen, M., Evensen, J. F., Biorklund, A., et al. (2001). A prospective study of quality of life in head and neck cancer patients Part I: At diagnosis. The Laryngoscope, 111(4 Pt 1), 669–680.
Gyori, E., Przestrzelski, C., Pona, I., Hagmann, M., Rath, T., Radtke, C., et al. (2018). Quality of life and functional assessment of facial palsy patients: A questionnaire study. International Journal of Surgery, 55, 92–97.
Ho, A. L., Scott, A. M., Klassen, A. F., Cano, S. J., Pusic, A. L., & Van Laeken, N. (2012). Measuring quality of life and patient satisfaction in facial paralysis patients: A systematic review of patient-reported outcome measures. Plastic and Reconstructive Surgery, 130(1), 91–99.
Choi, S. Y., Lee, E., Kim, E., Chung, M. K., Son, Y. I., Baek, C. H., et al. (2021). Clinical outcomes of bulky parotid gland cancers: Need for self-examination and screening program for early diagnosis of parotid tumors. BMC Cancer, 21(1), 178.
Liao, L. J., Hsu, W. L., Lo, W. C., Cheng, P. W., Shueng, P. W., & Hsieh, C. H. (2019). Health-related quality of life and utility in head and neck cancer survivors. BMC Cancer, 19(1), 425.
Weymuller, E. A., Yueh, B., Deleyiannis, F. W., Kuntz, A. L., Alsarraf, R., & Coltrera, M. D. (2000). Quality of life in patients with head and neck cancer: lessons learned from 549 prospectively evaluated patients. Archives of Otolaryngology–Head & Neck Surgery, 126(3), 329–335.
Babin, E., Sigston, E., Hitier, M., Dehesdin, D., Marie, J. P., & Choussy, O. (2008). Quality of life in head and neck cancers patients: Predictive factors, functional and psychosocial outcome. European Archives of Oto-Rhino-Laryngology, 265(3), 265–270.
de Graeff, A., de Leeuw, J. R., Ros, W. J., Hordijk, G. J., Blijham, G. H., & Winnubst, J. A. (2001). Sociodemographic factors and quality of life as prognostic indicators in head and neck cancer. European Journal of Cancer, 37(3), 332–339.
Sutherland, H. J., & Till, J. E. (1993). Quality of life assessments and levels of decision making: Differentiating objectives. Quality of Life Research, 2(4), 297–303.
Acknowledgements
None.
Funding
This study was supported by the Samsung Medical Center Research Project (no. OTA2101031).
Author information
Authors and Affiliations
Contributions
DK: study concepts, study design, quality control of data, data analysis and interpretation, writing–initial draft, and writing–review and editing; EK: data acquisition, quality control of data, data analysis and interpretation, writing–initial draft, and writing–review and editing; NC: data acquisition, quality control of data, data analysis and interpretation, statistical analysis, and writing–review and editing; HJK: data acquisition, quality control of data, data analysis and interpretation, statistical analysis, and writing–review and editing; JC: study concepts, study design, writing–review and editing; HSJ: study concepts, study design, quality control of data, data analysis and interpretation, writing–initial draft, and writing–review and editing.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
The study protocol was approved by the Institutional Review Board of Samsung Medical Center (no. 2015–06-132).
Consent to participate
Written informed consent was obtained from all participants.
Consent to publish
No individual person’s data.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Kang, D., Kim, E., Choi, N. et al. Pre-treatment quality of life in patients with salivary gland cancer in comparison with those of head and neck cancer patients. Qual Life Res 32, 1493–1506 (2023). https://doi.org/10.1007/s11136-022-03323-8
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11136-022-03323-8